Related Experiment Video
Updated: Feb 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Model diagnostics for the proportional hazards model with length-biased data
Chi Hyun Lee1, Jing Ning2, Yu Shen2
1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1411, Houston, TX, 77030, USA. clee9@mdanderson.org.
Abstract:
Length-biased data are frequently encountered in prevalent cohort studies. Many statistical methods have been developed to estimate the covariate effects on the survival outcomes arising from such data while properly adjusting for length-biased sampling. Among them, regression methods based on the proportional hazards model have been widely adopted. However, little work has focused on checking the proportional hazards model assumptions with length-biased data, which is essential to ensure the validity of inference. In this article, we propose a statistical tool for testing the assumed functional form of covariates and the proportional hazards assumption graphically and analytically under the setting of length-biased sampling, through a general class of multiparameter stochastic processes. The finite sample performance is examined through simulation studies, and the proposed methods are illustrated with the data from a cohort study of dementia in Canada.
More Related Videos
Related Concept Videos
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Sample Proportion and Population Proportion
Confirmation Biases
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

